FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306154920> ?p ?o ?g. }

• W4306154920 endingPage "60" @default.
• W4306154920 startingPage "47" @default.
• W4306154920 abstract "Determining the potential cardiotoxicity and pro-arrhythmic effects of drug candidates remains one of the most relevant issues in the drug development pipeline (DDP). New methods enabling to perform more representative preclinical in vitro studies by exploiting induced pluripotent stem cell-derived cardiomyocytes (iPSC-CM) are under investigation to increase the translational power of the outcomes. Here we present a pharmacological campaign conducted to evaluate the drug-induced QT alterations and arrhythmic events on uHeart, a 3D miniaturized in vitro model of human myocardium encompassing iPSC-CM and dermal fibroblasts embedded in fibrin. uHeart was mechanically trained resulting in synchronously beating cardiac microtissues in 1 week, characterized by a clear field potential (FP) signal that was recorded by means of an integrated electrical system. A drug screening protocol compliant with the new International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines was established and uHeart was employed for testing the effect of 11 compounds acting on single or multiple cardiac ion channels and well-known to elicit QT prolongation or arrhythmic events in clinics. The alterations of uHeart's electrophysiological parameters such as the beating period, the FP duration, the FP amplitude, and the detection of arrhythmic events prior and after drug administration at incremental doses were effectively analyzed through a custom-developed algorithm. Results demonstrated the ability of uHeart to successfully anticipate clinical outcome and to predict the QT prolongation with a sensitivity of 83.3%, a specificity of 100% and an accuracy of 91.6%. Cardiotoxic concentrations of drugs were notably detected in the range of the clinical highest blood drug concentration (Cmax), qualifying uHeart as a fit-to-purpose preclinical tool for cardiotoxicity studies." @default.
• W4306154920 created "2022-10-14" @default.
• W4306154920 creator A5009323150 @default.
• W4306154920 creator A5032437020 @default.
• W4306154920 creator A5038297883 @default.
• W4306154920 creator A5039803457 @default.
• W4306154920 creator A5052865089 @default.
• W4306154920 creator A5054009456 @default.
• W4306154920 creator A5081695706 @default.
• W4306154920 creator A5083934929 @default.
• W4306154920 creator A5089990584 @default.
• W4306154920 date "2022-10-13" @default.
• W4306154920 modified "2023-09-29" @default.
• W4306154920 title "Predicting human cardiac QT alterations and pro-arrhythmic effects of compounds with a 3D beating heart-on-chip platform" @default.
• W4306154920 cites W1935709356 @default.
• W4306154920 cites W1966140207 @default.
• W4306154920 cites W2007932208 @default.
• W4306154920 cites W2010293399 @default.
• W4306154920 cites W2014725906 @default.
• W4306154920 cites W2033765226 @default.
• W4306154920 cites W2052017927 @default.
• W4306154920 cites W2067884148 @default.
• W4306154920 cites W2074527519 @default.
• W4306154920 cites W2087204062 @default.
• W4306154920 cites W2098952554 @default.
• W4306154920 cites W2113927644 @default.
• W4306154920 cites W2128479327 @default.
• W4306154920 cites W2138757414 @default.
• W4306154920 cites W2170124735 @default.
• W4306154920 cites W2170377367 @default.
• W4306154920 cites W2193321641 @default.
• W4306154920 cites W2213652914 @default.
• W4306154920 cites W2302194794 @default.
• W4306154920 cites W2303371987 @default.
• W4306154920 cites W2415670168 @default.
• W4306154920 cites W2486842487 @default.
• W4306154920 cites W2527750418 @default.
• W4306154920 cites W2550437721 @default.
• W4306154920 cites W2559754868 @default.
• W4306154920 cites W2560528760 @default.
• W4306154920 cites W2626725994 @default.
• W4306154920 cites W2778287023 @default.
• W4306154920 cites W2790357275 @default.
• W4306154920 cites W2794616878 @default.
• W4306154920 cites W2801715451 @default.
• W4306154920 cites W2811435008 @default.
• W4306154920 cites W2893420171 @default.
• W4306154920 cites W2898529438 @default.
• W4306154920 cites W2898786667 @default.
• W4306154920 cites W2905249758 @default.
• W4306154920 cites W2941656913 @default.
• W4306154920 cites W2979409238 @default.
• W4306154920 cites W2986802075 @default.
• W4306154920 cites W2995908837 @default.
• W4306154920 cites W3000627274 @default.
• W4306154920 cites W3014691264 @default.
• W4306154920 cites W3019982879 @default.
• W4306154920 cites W3029730275 @default.
• W4306154920 cites W3073642655 @default.
• W4306154920 cites W3082864643 @default.
• W4306154920 cites W3112394955 @default.
• W4306154920 cites W3128054076 @default.
• W4306154920 cites W3200665526 @default.
• W4306154920 cites W4210294348 @default.
• W4306154920 cites W4210481166 @default.
• W4306154920 cites W4292371394 @default.
• W4306154920 cites W878990122 @default.
• W4306154920 doi "https://doi.org/10.1093/toxsci/kfac108" @default.
• W4306154920 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36226800" @default.
• W4306154920 hasPublicationYear "2022" @default.
• W4306154920 type Work @default.
• W4306154920 citedByCount "4" @default.
• W4306154920 countsByYear W43061549202023 @default.
• W4306154920 crossrefType "journal-article" @default.
• W4306154920 hasAuthorship W4306154920A5009323150 @default.
• W4306154920 hasAuthorship W4306154920A5032437020 @default.
• W4306154920 hasAuthorship W4306154920A5038297883 @default.
• W4306154920 hasAuthorship W4306154920A5039803457 @default.
• W4306154920 hasAuthorship W4306154920A5052865089 @default.
• W4306154920 hasAuthorship W4306154920A5054009456 @default.
• W4306154920 hasAuthorship W4306154920A5081695706 @default.
• W4306154920 hasAuthorship W4306154920A5083934929 @default.
• W4306154920 hasAuthorship W4306154920A5089990584 @default.
• W4306154920 hasBestOaLocation W43061549201 @default.
• W4306154920 hasConcept C104317684 @default.
• W4306154920 hasConcept C107459253 @default.
• W4306154920 hasConcept C118441451 @default.
• W4306154920 hasConcept C126322002 @default.
• W4306154920 hasConcept C145103041 @default.
• W4306154920 hasConcept C164705383 @default.
• W4306154920 hasConcept C185263204 @default.
• W4306154920 hasConcept C185592680 @default.
• W4306154920 hasConcept C2776190711 @default.
• W4306154920 hasConcept C2778233292 @default.
• W4306154920 hasConcept C2779362680 @default.
• W4306154920 hasConcept C2780035454 @default.
• W4306154920 hasConcept C29730261 @default.
• W4306154920 hasConcept C2983437453 @default.

• next